Catalyst Wire Dossier Catalyst Wire Dossier

SLV334

· Solvay Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SLV334, covering 2010-09-17 to 2011-09-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury. [Phase 2]

See pricing